novel treatments

Research in Review
Hypomethylating Agents Improve Survival in Older Patients With CMML
06/19/2017
JCP Editors
Older patients with chronic myelomonocytic leukemia (CMML) who are treated with hypomethylating agents reduce their risk of disease-related mortality by 28%, according to new research published in Cancer (published...
Older patients with chronic myelomonocytic leukemia (CMML) who are treated with hypomethylating agents reduce their risk of disease-related mortality by 28%, according to new research published in Cancer (published...
Older...
06/19/2017
Journal of Clinical Pathways
Research in Review
High Response Rates With New Treatment for Aggressive B-Cell Lymphoma
06/13/2017
JCP Editors
In a recent trial, researchers determined complete response rates in patients with aggressive B-cell lymphomas after treatment with new a CAR T-cell product. ----- Related Content B-Cell ALL Disease Burden May...
In a recent trial, researchers determined complete response rates in patients with aggressive B-cell lymphomas after treatment with new a CAR T-cell product. ----- Related Content B-Cell ALL Disease Burden May...
In a...
06/13/2017
Journal of Clinical Pathways
Research in Review
CAR T-Cells May Have Therapeutic Value in Solid Cancers
06/07/2017
JCP Editors
Chimeric antigen receptor (CAR) T-cells may elicit responses in solid cancers by inducing cancer cell death and the release of tumor antigens that could stimulate T-cell activity, according to research presented at...
Chimeric antigen receptor (CAR) T-cells may elicit responses in solid cancers by inducing cancer cell death and the release of tumor antigens that could stimulate T-cell activity, according to research presented at...
...
06/07/2017
Journal of Clinical Pathways
Gemcitabine-Based Chemoradiation Effective Bladder Cancer Treatment for Underdeveloped Nations
06/04/2017
JCP Editors
Neoadjuvant gemcitabine-based chemotherapy, followed by gemcitabine-based concomitant chemoradiation, may aid in bladder preservation for patients receiving treatment for muscle-invasive bladder cancer in...
Neoadjuvant gemcitabine-based chemotherapy, followed by gemcitabine-based concomitant chemoradiation, may aid in bladder preservation for patients receiving treatment for muscle-invasive bladder cancer in...
...
06/04/2017
Journal of Clinical Pathways
Research in Review
Novel Therapy Induces High Response Rate in Metastatic NSCLC
06/01/2017
JCP Editors
A novel antibody-drug conjugate is well tolerated and induces durable responses in pretreated patients with advanced non-small cell lung cancer (NSCLC), according to research published in the Journal of Clinical...
A novel antibody-drug conjugate is well tolerated and induces durable responses in pretreated patients with advanced non-small cell lung cancer (NSCLC), according to research published in the Journal of Clinical...
A...
06/01/2017
Journal of Clinical Pathways
Research in Review
Dose-Escalated Therapy May Be Curative for Multiple B-Cell Malignancies
04/26/2017
JCP Editors
Dose-escalated therapy involving a single agent produced complete and partial responses in patients with different B-cell malignancies. ----- Related Content Maintenance Therapy Effective in Treating Diffuse Large...
Dose-escalated therapy involving a single agent produced complete and partial responses in patients with different B-cell malignancies. ----- Related Content Maintenance Therapy Effective in Treating Diffuse Large...
...
04/26/2017
Journal of Clinical Pathways
Research in Review
Maintenance Therapy After Autologous Stem Cell Transplant Improves Survival in MCL
04/18/2017
JCP Editors
Younger patients with mantle cell lymphoma (MCL) who receive an autologous hematopoietic cell transplant after an induction regimen are more likely to prolong their survival with maintenance therapy. ----- Related...
Younger patients with mantle cell lymphoma (MCL) who receive an autologous hematopoietic cell transplant after an induction regimen are more likely to prolong their survival with maintenance therapy. ----- Related...
...
04/18/2017
Journal of Clinical Pathways
Research in Review
Maintenance Therapy Effective in Treating Diffuse Large B-Cell Lymphoma
04/12/2017
JCP Editors
Maintenance therapy with a targeting agent may provide survival benefits beyond first- and second-line chemotherapy in patients with diffuse large B-cell lymphoma, according to an analysis published in PLOS One...
Maintenance therapy with a targeting agent may provide survival benefits beyond first- and second-line chemotherapy in patients with diffuse large B-cell lymphoma, according to an analysis published in PLOS One...
...
04/12/2017
Journal of Clinical Pathways
Research in Review
Combined Treatment Approach Improves Survival for Patients With Glioblastoma
04/03/2017
JCP Editors
A combination therapy for patients with newly diagnosed glioblastoma maintains improvement in overall survival (OS) after 5 years, according to recently published results of a phase III trial. ----- Related...
A combination therapy for patients with newly diagnosed glioblastoma maintains improvement in overall survival (OS) after 5 years, according to recently published results of a phase III trial. ----- Related...
A...
04/03/2017
Journal of Clinical Pathways
Research in Review
Meta-Analysis Reveals Optimal Combination Therapy for Multiple Myeloma
03/24/2017
JCP Editors
A triple-combination treatment strategy is the most effective therapy for patients with relapsed or refractory multiple myeloma, according to a meta-analysis published in the Journal of Clinical Oncology (published...
A triple-combination treatment strategy is the most effective therapy for patients with relapsed or refractory multiple myeloma, according to a meta-analysis published in the Journal of Clinical Oncology (published...
A...
03/24/2017
Journal of Clinical Pathways

Upcoming Events

February 2 ⁠–⁠ February 5
LLM Winter Symposium
February 7 ⁠–⁠ February 9
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
GD Solid Tumors
March 22 ⁠–⁠ March 23
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 4
WoundCon
May 1 ⁠–⁠ May 3
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use